ClinicalTrials.gov
ClinicalTrials.gov Menu

Prevention of Nosocomial Infections (CleanKids) (CleanKids)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03360877
Recruitment Status : Active, not recruiting
First Posted : December 4, 2017
Last Update Posted : August 22, 2018
Sponsor:
Collaborators:
Minisitry of Public Health, Niger
Medecins Sans Frontieres, Netherlands
Information provided by (Responsible Party):
Epicentre

November 28, 2017
December 4, 2017
August 22, 2018
September 5, 2016
November 30, 2017   (Final data collection date for primary outcome measure)
Evaluation of the reduction of the incidence of nosocomial bacteremia [ Time Frame: Between 48 hours after hospitalization and less than 28 days after hospital release ]
To determine whether, when accompanied by the caregiver, children with severe acute malnutrition (SAM), daily cleaning with wipes containing 2% chlorhexidine gluconate (HCG) reduces the incidence of nosocomial bacteremia suspected and / or confirmed by the laboratory compared to baseline data and compared to daily soap and water cleanup administered by the caregiver.
Same as current
Complete list of historical versions of study NCT03360877 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Prevention of Nosocomial Infections (CleanKids)
Assessing the Risk of Hospital-acquired Infection and Multi-drug Resistance Among Hospitalized Severe Acutely Malnourished Children

While the standardization of treatment protocols for Severe Acute Malnutrition (SAM) has helped to reduce historically high mortality, mortality in inpatient settings remains substantial, likely due to the severity of complications associated with late presentation and health-care associated infection (HCAI).

The purpose of this study is to serve as an important stand-alone description to inform the understanding of the magnitude of the problem and help guide implementation of measures to reduce the risk of nosocomial infection and multi-drug resistance.

This study is designed as a cross-sectional, non-randomized, two-site, four-phase study: an initial baseline period, two intervention periods, and a final interruption period.

This is a descriptive study to collect information on the risk of HCAIs in the MSF-supported inpatient nutritional treatment centers. Information on key clinical indicators will be collected regularly according to the routine program procedures from the time of admission to discharge. All children will undergo a blood draw for culture at time of admission and at the time of any suspected hospital-acquired bloodstream infection. As part of active surveillance for bacterial colonization, including multi-drug resistant organisms, all children will undergo nasal and rectal swabs at the time of admission, suspected infection, and discharge. Data will provide an estimate of nosocomial infection incidence under routine circumstances and inform sample size calculations if further study is warranted.

Interventional
Not Applicable
Intervention Model: Single Group Assignment
Intervention Model Description:
The initial 8-month baseline period will be used to collect data on the evaluation criteria of interest prior to the administration of any intervention of the study and will develop appropriate pedagogical tools to support the uptake of each cleaning strategy during subsequent intervention periods. After the reference period, a one-month introductory period will allow the organization of the first intervention at each site (ie - a soap and water cleansing administered by the carers in a structure or - a cleaning HCG administered by caregivers in the other facility) followed by eight months of active follow-up of the study with the first intervention. Following the eight months of active follow-up with the first intervention, there will be a crossover with an introductory period of one month and eight months of active follow-up with the other intervention. A final period of interruption will occur during the last eight months of the study.
Masking: None (Open Label)
Primary Purpose: Prevention
  • Severe Acute Malnutrition
  • Health Care Associated Infection
  • Multi Drug Resistant Organisms
Other: Health-care associated infection (HCAI)
Cleaning of the child with soap and water administered by the child's accompanying person in a structure or - a cleaning of the child with chlorhexidine gluconate administered by the child's accompanying person in the other structure
Health-care associated infection
Intervention: Other: Health-care associated infection (HCAI)
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
4944
1600
December 31, 2018
November 30, 2017   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  1. 6 to 59 months old
  2. severe acute malnutrition with medical complications
  3. parent / caregiver signing written informed consent

Exclusion Criteria:

  1. health condition that does not allow blood draw
  2. contraindication to the use of soap or Chlorhexidine gluconate, as recommended by the product
  3. refusal to discontinue the use of skin care products that are incompatible with Chlorhexidine gluconate according to the product's directions for use
Sexes Eligible for Study: All
6 Months to 59 Months   (Child)
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
 
NCT03360877
NE-949
No
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Not Provided
Epicentre
Epicentre
  • Minisitry of Public Health, Niger
  • Medecins Sans Frontieres, Netherlands
Not Provided
Epicentre
August 2018

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP